Improving Adolescent and Young Adult Sexual Health through Routine Screening and Preventive Care

Maria Trent
Maria Trent, MD, MPH, FAAP, FSAHM

Jointly provided by Postgraduate Institute for Medicine and American Sexual Health Association. This activity is supported by an independent educational grant from Labcorp.

Release date: June 30, 2022
Expiration date: June 30, 2023

Estimated time to complete activity: 45 minutes

Target Audience

This activity is intended for physicians, physician assistants, registered nurses and nurse practitioners engaged in the engaged in the care of women.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Recognize the importance of proactively addressing sexuality issues with adolescent and young adult patients.
  • Identify STI screening guidelines for adolescent and young adult populations.
  • Describe an opt-out strategy for chlamydia and gonorrhea screening in an adolescent patient population.
  • Utilize language that normalizes chlamydia screening and makes it a routine part of care.


Maria Trent, MD, MPH, FAAP, FSAHM 
Professor of Pediatrics, American Health, and Nursing
Chief of the Division of Adolescent/ Young Adult Medicine, and the Senior Associate Dean of Diversity and Inclusive Excellence
Johns Hopkins University School of Medicine

Denise Linton, DNS, FNP, FAANP
Professor (Retired)
University of Louisiana at Lafayette

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Maria Trent, MD, MPH, FAAP, FSAHM
Dr. Trent has disclosed relationships with Hologic, ReachMD, Merck, Inc, Church and Dwight, Inc., and SpeeDx, LLC.

Denise Linton, DNS, FNP, FAANP
Ms. Linton has nothing to disclose.

The PIM planners and others have nothing to disclose. The American Sexual Health Association planners and others have nothing to disclose.

Method of Participation and Request for Credit

This activity has expired and CE credit is no longer available.

Joint Accreditation Statement

Jointly Accredited Provider LogoIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and American Sexual Health Association. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is .75 contact hours.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


HEADSS AssessmentA tool to help identify an adolescent’s risk and protective factors during each visit. Includes questions to ask in different categories, including Home, Education/Employment, Activities, Drugs, Sexuality, Suicide, and Safety.

SSHADESS Assessment
The SSHADESS screening is a modified HEADSS screening. This resource includes examples of key questions you might ask as well as related video content.